GC Biopharma
Korea - YonginPharmaceutical
Focus: GC Biopharma is a Korean pharmaceutical company specializing in plasma products and vaccines, with a diverse pipeline spanning rare diseases, infectious diseases, and immunology. The company operates from Yongin, South Korea with a significant clinical development footprint across multiple therapeutic areas.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About GC Biopharma
AI assessmentNot HiringNo open roles listed right now. Follow GC Biopharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Hunterase
Stable
Growth
Phase 3 program for ultra-rare lysosomal storage disorder with significant unmet need and potential commercial opportunity.
GreenGene / GreenGene™ F
Help build intelligence for GC Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.